Lv2
168 积分 2022-10-30 加入
Hepatic antifibrotic effects of Bezafibrate in vitro and in vivo models of liver fibrosis
3个月前
已完结
Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis
3个月前
已完结
In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β
3个月前
已完结
A Novel Lipid Nanoparticle NBF-006 Encapsulating Glutathione S-Transferase P siRNA for the Treatment of KRAS-Driven Non–small Cell Lung Cancer
5个月前
已完结
Abstract ND11: The discovery and characterization of ION-537: A next generation antisense oligonucleotide inhibitor of YAP1 in preclinical cancer models
5个月前
已完结
Perspectives on the current and emerging chemical androgen receptor antagonists for the treatment of prostate cancer
5个月前
已完结
Preclinical and Clinical Pharmacokinetics of JNJ‐75220795, an siRNA Therapeutic Targeting PNPLA3, for Metabolic Dysfunction‐Associated Steatohepatitis
5个月前
已完结
17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease
5个月前
已完结
Unveiling MASH: A Comprehensive Review Highlighting Experimental Insights, Molecular Pathogenesis, and Therapeutic Approaches
5个月前
已完结
Resmetirom, the first FDA-approved drug for MASH: From drug discovery and action mechanisms to clinical trials
5个月前
已完结
皖公网安备34019202002308
